Léčebné možnosti pacientů s CMP se v posledních dekádách dramaticky změnily díky pokroku v rekanalizační terapii a dalších intervenčních postupech. Zatímco akutní léčba ischemické CMP se stala vysoce standardizovanou, v oblasti sekundární prevence a rehabilitace dosud existuje značná variabilita. Totéž platí pro management pacientů s intracerebrálním krvácením. Klíčovým krokem k dosažení standardizace napříč zdravotnickými zařízeními je sjednocení lékařské dokumentace, zejména propouštěcí zprávy. Tento článek představuje doporučený standard propouštěcí zprávy pro pacienty s ischemickou i hemoragickou CMP. Jeho hlavním cílem je zajistit jednotnou kvalitu zdravotní péče, zlepšit komunikaci mezi zdravotníky, podpořit sekundární prevenci a usnadnit digitalizaci a vědecký výzkum. Doporučený standard definuje minimální sadu klíčových informací, které by měla obsahovat každá propouštěcí zpráva pacientů s CMP. Součástí dokumentu jsou také šablony příjmové zprávy a epikrízy, které reflektují požadavky mezinárodního registru RES-Q a mohou usnadnit sběr dat. Implementace tohoto standardu přinese nejen snížení administrativní zátěže lékařů, ale zároveň umožní lepší kontrolu kvality péče a zajištění souladu s aktuálními klinickými doporučeními. Standardizace dokumentace představuje důležitý krok k optimalizaci léčby CMP a ke zlepšení dlouhodobých výsledků pacientů.
Treatment options for patients with stroke have dramatically evolved in recent decades due to advances in recanalization therapy and other interventional procedures. While acute treatment of ischemic stroke has become highly standardized, there remains significant variability in the areas of secondary prevention and rehabilitation. The same applies to the management of patients with intracerebral hemorrhage. A key step toward achieving standardization across healthcare facilities is the unification of medical documentation, particularly discharge reports. This article presents a recommended standard for discharge reports for patients with both ischemic and hemorrhagic strokes. Its main goal is to ensure uniform quality of healthcare, improve communication among medical professionals, support secondary prevention, and facilitate digitalization and scientific research. The recommended standard defines the minimum set of essential information that every discharge report for stroke patients should contain. The document also includes templates for admission reports and epicrises, which reflect the requirements of the international RES-Q registry and can facilitate data collection. The implementation of this standard will not only reduce the administrative burden on physicians, but also enable better quality control of care and ensure compliance with current clinical guidelines. Standardizing documentation represents an important step toward optimizing stroke treatment and improving long-term patient outcomes.
- MeSH
- Stroke * MeSH
- Ischemic Stroke MeSH
- Humans MeSH
- Patient Discharge Summaries * standards MeSH
- Check Tag
- Humans MeSH
- Publication type
- Practice Guideline MeSH
Východisko: Odběr anamnézy pomocí validovaných dotazníků neodmyslitelně patří k urogynekologickému vyšetření a sledování. Elektronická forma vyplňování dotazníků zjednodušuje sběr a zpracování dat, ale její použití může být náročné pro starší pacientky. Proto jsme vyvinuli systém MESS (Medical Electronic Survey System), který usnadňuje vyplňování dotazníků na tabletu, s důrazem na ochranu osobních údajů a uživatelskou přívětivost. Cíl: Porovnat spokojenost pacientek a jednoduchost použití mezi systémy Google Formuláře a MESS. Metodika: V prospektivní studii jsme analyzovali 193 dotazníků spokojenosti vyplněných pomocí Google Formuláře (2013–2015) a 329 dotazníků vyplněných pomocí MESS (2019–2020) spolu s ostatními dotazníky. Data byla vyhodnocena pomocí Fisherova exaktního testu či Wilcoxonova testu dle rozložení normality s hladinou významnosti p < 0,05. Výsledky: Elektronická forma vyplňování vyhovovala více pacientkám ve skupině MESS (84,5 vs. 65,6 %; p < 0,05). Vyplňování dotazníků elektronicky bylo snadné a velmi snadné pro 89,1 % s použitím MESS vs. 68,7 % pomocí Google Formuláře (p < 0,05). Nejvýraznější rozdíl byl pozorován u žen ve věku 60–69 let, kde 92,8 % pacientek vyplnilo dotazník samostatně s MESS oproti 36,9 % u Google Formuláře. U žen mladších 60 let nebyly rozdíly statisticky významné. Závěr: Systém MESS zefektivnil práci lékařů a zpřístupnil metodu elektronického vyplňování i starším pacientkám s poruchami pánevního dna.
Background: Evaluation of the quality of life using validated measures is an essential part of urogynecology examination and follow-up. Questionnaires administered in paper form generate paper waste or high demands for storage. Score calculation for some questionnaires may be demanding and time-consuming. The electronic format of completing questionnaires simplifies data collection and processing, but may be challenging for older patients. We developed a Medical Electronic Survey System (MESS), which facilitates completion of questionnaires on a tablet PC with an emphasis on data protection and user-friendliness for the elderly. Objective: To compare patient satisfaction and ease of use between Google Forms and MESS. Methods: This was a prospective cohort study comparing the answers to a satisfaction questionnaire completed using Google Forms (193 questionnaires between 2013–2015) and MESS (329 questionnaires between 2019–2020), along with other clinically used validated questionnaires. The answers to the questionnaire were compared using a Fisher’s Exact Test or a Wilcoxon Two Sample test, with a significance level of P < 0.05. Results: The electronic form of questionnaire completion suited more women in case of MESS (84.5 vs. 65.6%; P < 0.05). Completing questionnaires electronically was rated as easy or very easy by 89.1% of patients using MESS compared to 68.7% using Google Forms; P < 0.05. The electronic form of filling-in the questionnaires was very difficult or impossible especially for women using Google Forms (31 vs. 11%; P < 0.05). The major difference in questionnaire completion without any help was observed in the age group 60–69 years. No differences were observed in women under 60 years of age. All clinicians observed significant facilitation of their work. Conclusion: MESS has made the method of electronic questionnaire completion available even to elderly patients with pelvic floor disorders. It was positively accepted even by patients who are not familiar with any electronic devices.
- Keywords
- Google formuláře, MESS,
- MeSH
- Adult MeSH
- Electronic Health Records * statistics & numerical data MeSH
- Middle Aged MeSH
- Humans MeSH
- Pelvic Floor Disorders diagnosis MeSH
- Prospective Studies MeSH
- Surveys and Questionnaires MeSH
- Data Collection methods MeSH
- Aged MeSH
- Patient Satisfaction * statistics & numerical data MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
Článek poskytuje průvodce převazem nehojících se ran, který je klíčový pro prevenci infekcí, podporu hojení a zvýšení komfortu pacienta. Popisuje základní kroky, počínaje hygienou rukou, přípravou materiálu, prostředí a ochranných pomůcek, až po aplikaci krytí a dokumentaci. Důraz je kladen na význam individuálního přístupu k pacientovi, pravidelné sledování stavu rány a dodržování nejnovějších postupů v péči o rány.
The article provides a practical guide to changing dressings for non-healing wounds, essential for preventing infections, promoting healing, and improving patient comfort. It outlines the fundamental steps, starting with hand hygiene, preparation of materials, environment, and protective equipment, followed by the application of wound dressings and documentation. Emphasis is placed on the importance of an individualized approach to the patient, regular wound condition monitoring, and adherence to the latest wound care practices.
- Keywords
- převazy ran,
- MeSH
- Medical Records MeSH
- Debridement classification methods MeSH
- Wound Healing MeSH
- Hygiene MeSH
- Humans MeSH
- Bandages classification MeSH
- Protective Devices MeSH
- Wounds and Injuries * nursing pathology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Review MeSH
Massive bleeding causes approximately 50% of deaths in patients with major trauma. Most patients die within 6 h of injury, which is preventable in at least 10% of cases. For these patients, early activation of the massive transfusion protocol (MTP) is a critical survival factor. With severe trauma, high-mobility group box 1 (HMGB-1, i.e., amphoterin) is released into the blood, and its levels correlate with the development of a systemic inflammatory response, traumatic coagulopathy, and fibrinolysis. Previous work has shown that higher levels of HMGB-1 are associated with a higher use of red blood cell transfusions. We conducted a retrospective analysis of previous prospective single-center study to assess the value of admission HMGB-1 levels in predicting activation of MTP in the emergency department. From July 11, 2019, to April 23, 2022, a total of 104 consecutive adult patients with severe trauma (injury severity score > 16) were enrolled. A blood sample was taken at admission, and HMGB-1 was measured. MTP activation in the emergency department was recorded in the study documentation. The total amount of blood products and fibrinogen administered to patients within 6 h of admission was monitored. Among those patients with massive bleeding requiring MTP activation, we found significantly higher levels of HMGB-1 compared to patients without MTP activation (median [interquartile range]: 84.3 μg/L [34.2-145.9] vs. 21.1 μg/L [15.7-30.4]; p < 0.001). HMGB-1 level showed good performance in predicting MTP activation, with an area under the receiver operating characteristic curve of 0.84 (95% CI 0.75-0.93) and a cut-off value of 30.55 μg/L. HMGB-1 levels correlated significantly with the number of red blood cell units (rs [95% CI] 0.46 [0.28-0.61]; p < 0.001), units of fresh frozen plasma (rs 0.46 [0.27-0.61]; p < 0.001), platelets (rs 0.48 [0.30-0.62]; p < 0.001), and fibrinogen (rs 0.48 [0.32-0.62]; p < 0.001) administered in the first 6 h after hospital admission. Admission HMGB-1 levels reliably predict severe bleeding requiring MTP activation in the emergency department and correlate with the amount of blood products and fibrinogen administered during the first 6 h of hemorrhagic shock resuscitation.Trial registration: NCT03986736. Registration date: June 4, 2019.
- MeSH
- Biomarkers blood MeSH
- Adult MeSH
- Blood Transfusion * methods MeSH
- Hemorrhage * blood therapy etiology MeSH
- Middle Aged MeSH
- Humans MeSH
- Prospective Studies MeSH
- HMGB1 Protein * blood MeSH
- Wounds and Injuries * blood therapy complications MeSH
- Retrospective Studies MeSH
- Aged MeSH
- Injury Severity Score MeSH
- Emergency Service, Hospital MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
Introduction and Importance: Some experimental studies on brain injury associated with traumatic brain injury (TBI) and hypoxic-ischaemic encephalopathy (HIE) reveal a positive effect of hyperbaric oxygen therapy (HBOT). However, in clinical medicine, most of the scientific evidence available in the current literature relates only to TBI. Methods: The primary objective is to empirically assess the efficacy of HBOT in mitigating the symptoms of disability associated with brain injury in children, with a view to elucidating its therapeutic potential and clinical benefits. Outcomes: A total of 21 patients have been treated with HBOT. The mean age was 6±4.6 years. There were 12 cases (57%) of TBI, 8 cases (38%) of HIE and 1 case (5%) of ischaemic stroke. The mean initial Glasgow Coma Scale (GCS) at hospital admission immediately after accident was 3.3±0.9. The mean time from injury to HBOT was 5.2 ± 3.8 weeks. The mean number of HBOT exposures was 10±4.3. The mean GCS pre-HBOT was 10.7±3.7 and 12.3±3.4 (p=0.004) after post-HBOT, respectively. The mean Glasgow Outcome Scale (GOS) was 3.3±0.8 pre-HBOT, and 3.9±1.1 (p<0.001) after post-HBOT, respectively. Eighteen cases were included in response to HBOT assessment. Six cases (33%) were evaluated as large clinically significant response (CSR), 7 cases (39%) were evaluated as partial response with minimally important difference (MID). Five cases (28%) were evaluated as non-response. The results showed better response to HBOT in cases of starting HBOT up to 4 weeks (p=0.02) after the injury. There was no serious HBOT-related complication or injury. Conclusion: Results of our study demonstrate both clinical and statistically significant patient response to HBOT. Our data also suggest that the earlier HBOT started after diagnosis up to 4 weeks, the more pronounced patients' response to HBOT was achieved. The provision of HBOT to pediatric patients is feasible in large regional hyperbaric centers.
- MeSH
- Child MeSH
- Glasgow Coma Scale * MeSH
- Glasgow Outcome Scale MeSH
- Hyperbaric Oxygenation * methods MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Hypoxia-Ischemia, Brain * therapy MeSH
- Brain Injuries therapy MeSH
- Child, Preschool MeSH
- Retrospective Studies MeSH
- Brain Injuries, Traumatic therapy MeSH
- Treatment Outcome MeSH
- Check Tag
- Child MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
People living with diabetes have many medical devices available to assist with disease management. A critical aspect that must be considered is how systems for continuous glucose monitoring and insulin pumps communicate with each other and how the data generated by these devices can be downloaded, integrated, presented and used. Not only is interoperability associated with practical challenges, but also devices must adhere to all aspects of regulatory and legal frameworks. Key issues around interoperability in terms of data ownership, privacy and the limitations of interoperability include where the responsibility/liability for device and data interoperability lies and the need for standard data-sharing protocols to allow the seamless integration of data from different sources. There is a need for standardised protocols for the open and transparent handling of data and secure integration of data into electronic health records. Here, we discuss the current status of interoperability in medical devices and data used in diabetes therapy, as well as regulatory and legal issues surrounding both device and data interoperability, focusing on Europe (including the UK) and the USA. We also discuss a potential future landscape in which a clear and transparent framework for interoperability and data handling also fulfils the needs of people living with diabetes and healthcare professionals.
- MeSH
- Diabetes Mellitus * drug therapy MeSH
- Electronic Health Records MeSH
- Blood Glucose MeSH
- Humans MeSH
- Blood Glucose Self-Monitoring * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Geographicals
- United Kingdom MeSH
- MeSH
- Medical Records legislation & jurisprudence MeSH
- Endodontics methods legislation & jurisprudence MeSH
- Communication MeSH
- Humans MeSH
- Liability, Legal MeSH
- Jurisprudence MeSH
- Legislation as Topic * MeSH
- Expert Testimony * legislation & jurisprudence MeSH
- Dentists * legislation & jurisprudence MeSH
- Check Tag
- Humans MeSH
- MeSH
- Medical Records Systems, Computerized * legislation & jurisprudence MeSH
- Humans MeSH
- Health Care Reform methods MeSH
- Legislation, Medical MeSH
- Check Tag
- Humans MeSH
- Publication type
- Newspaper Article MeSH
